ReviewClinical pharmacokinetics2014

Clinical pharmacokinetics and pharmacodynamics of dapagliflozin, a selective inhibitor of sodium-glucose co-transporter type 2.

Sreeneeranj Kasichayanula et al.PubMed ↗Publisher ↗

No numbers read from the abstract.